[1] |
World Health Organization. Global tuberculosis report 2024. Gevena: World Health Organization, 2024.
|
[2] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09.
|
[3] |
黄银霞, 潘丽萍, 张宗德. 结核病实验室诊断技术研究进展. 北京医学, 2023, 45(10):893-898. doi:10.15932/j.0253-9713.2023.10.013.
|
[4] |
World Health Organization. WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 3rd ed. Gevena:World Health Organization, 2023.
|
[5] |
Morris K. WHO recommends against inaccurate tuberculosis tests. Lancet, 2011, 377(9760):113-114. doi:10.1016/s0140-6736(11)60005-6.
pmid: 21226229
|
[6] |
Yan ZH, Yi L, Wei PJ, et al. Evaluation of panels of Mycobacterium tuberculosis antigens for serodiagnosis of tuberculosis. Int J Tuberc Lung Dis, 2018, 22(8):959-965. doi:10.5588/ijtld.18.0060.
pmid: 29991408
|
[7] |
World Health Organization. Commercial sero-diagnostic tests for diagnosis of tuberculosis:policystatement. Geneva:World Health Organization, 2011.
|
[8] |
World Health Organization. WHO warns against the use of inaccurate blood tests for active tuberculosis. Geneva:World Health Organization, 2011.
|
[9] |
孙照刚. 重视结核分枝杆菌抗原检测技术研发. 中国防痨杂志, 2022, 44(2):120-124. doi:10.19982/j.issn.1000-6621.20210558.
|
[10] |
阳幼荣, 王全立, 吴雪琼, 等. 结核分枝杆菌12种抗原在结核病血清学诊断中应用价值的研究. 中国防痨杂志, 2011, 33(8):486-491. doi:10.19982/j.issn.1000-6621.2011.08.006.
|
[11] |
Cao T, Lyu L, Jia H, et al. A Two-Way Proteome Microarray Strategy to Identify Novel Mycobacterium tuberculosis-Human Interactors. Front Cell Infect Microbiol, 2019, 9:65. doi:10.3389/fcimb.2019.00065.
|
[12] |
中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 2017-11-09.
|
[13] |
赵雁林, 逄宇. 结核病实验室检验规程. 北京: 人民卫生出版社, 2015.
|
[14] |
Feruglio SL, Kvale D, Dyrhol-Riise AM. T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis. Scand J Immunol, 2017, 85(2):138-146. doi:10.1111/sji.12511.
pmid: 27862137
|
[15] |
He X, Jiang HW, Chen H, et al. Systematic Identification of Mycobacterium tuberculosis Effectors Reveals that BfrB Suppresses Innate Immunity. Mol Cell Proteomics, 2017, 16(12):2243-2253. doi:10.1074/mcp.RA117.000296.
|
[16] |
唐宇龙, 杨华, 刘湘新, 等. 三种结核分枝杆菌分泌蛋白的抗体制备及其在抗原检测中的应用. 中华传染病杂志, 2007, 25(10):597-600. doi:10.3760/j.issn:1000-6680.2007.10.005.
|
[17] |
段绍琪. 免疫组化检测结核分枝杆菌分泌抗原Ag85B、ESAT-6和CFP10在肺结核诊断中的意义. 南充:川北医学院, 2022. doi:10.27755/d.cnki.gcbyx.2022.000244.
|
[18] |
Sun J, Zhou X, Yu J, et al. Diagnostic value of tuberculosis-Specific antigens Ag85B, ESAT-6 and CFP10 in pulmonary tuberculosis. J Clin Tuberc Other Mycobact Dis, 2024, 37:100486. doi:10.1016/j.jctube.2024.100486.
|
[19] |
Broger T, Tsionksy M, Mathew A, et al. Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients. PLoS One, 2019, 14(4):e0215443. doi:10.1371/journal.pone.0215443.
|
[20] |
Flores LL, Steingart KR, Dendukuri N, et al. Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis. Clin Vaccine Immunol, 2011, 18(10):1616-1627. doi:10.1128/CVI.05205-11.
pmid: 21832100
|
[21] |
Brock M, Hanlon D, Zhao M, et al. Detection of mycobacterial lipoarabinomannan in serum for diagnosis of active tuberculosis. Diagn Microbiol Infect Dis, 2020, 96(2):114937. doi:10.1016/j.diagmicrobio.2019.114937.
|
[22] |
张昆南, 许自强, 王朝东, 等. 脑脊液中检测结核分枝杆菌特异性抗原对结核性脑膜炎的诊断意义. 中华神经科杂志, 2011, 44(2):86-90. doi:10.3760/cma.j.issn.1006-7876.2011.02.004.
|
[23] |
World Health Organization. High priority target product profiles for new tuberculosis diagnostics:report of a consensus meeting. Geneva: World Health Organization, 2014.
|
[24] |
杨春龙, 周林, 陈明亭. 《病原学检测阴性肺结核诊断流程(T/CHATA 008—2020)》解读. 中国防痨杂志, 2021, 43(11):1116-1119. doi:10.3969/j.issn.1000-6621.2021.11.003.
|